• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study reveals an elevated cancer risk in Holocaust survivors

Bioengineer by Bioengineer
July 10, 2017
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study indicates that survivors of the Holocaust have experienced a small but consistent increase in the risk of developing cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings offer an example of how extreme population-level tragedies can have an impact on health.

Holocaust survivors were exposed to a variety of factors that have been linked with cancer. Siegal Sadetzki, MD, MPH, of the Chaim Sheba Medical Center in Israel, and her colleagues wondered whether the starvation, overcrowding, infectious diseases, and psychological stress that survivors endured might have contributed to the development of cancer in some individuals.

To investigate, the team studied 152,622 Holocaust survivors who were followed for more than 45 years. Two separate definitions of exposure were used. One definition was based on the individual's entitlement for compensation according to a set of laws. The other was based on the country of origin, using a classification of countries during the war into those that were directly governed by Nazi Germany and other non-occupied countries.

Cancer was diagnosed in 22 percent of those who were granted compensation for suffering persecution during the war versus 16 percent of those who were denied compensation. Survivors who were granted compensation had a six percent higher risk of developing any type of cancer than those who were denied compensation, and they had a 12 percent increased risk for colorectal cancer and a 37 percent increased risk for lung cancer. Those born in occupied countries had an eight percent increased risk of developing any cancer than those born in non-occupied countries, as well as eight percent and 12 percent increased risks of colorectal cancer and lung cancer, respectively. The investigators observed no elevated risks for breast cancer and gynecologic cancers among female survivors.

"The data emphasize the importance of learning about the combined effect of several exposures occurring intensely and contemporaneously on cancer risk, such as those that unfortunately occurred during World War II," said Prof. Sadetzki. "Such inspection cannot be conducted by experimental studies and could only be evaluated by using observational epidemiological surveys."

An accompanying editorial notes that the associations reported by Prof. Sadetzki and colleagues between the extreme deprivation experienced by Holocaust survivors and cancer may also have parallels with other extreme population-level events, including in racial/ethnic minority groups who experience severe social deprivation over time.

###

Additional Information

Full Citations

"Cancer Risk Among Holocaust Survivors in Israel–A Nationwide Study." Siegal Sadetzki, Angela Chetrit, Laurence S. Freedman, Nina Hakak, Micha Barchana, Raphael Catane, and Mordechai Shani. CANCER; Published Online: July 10, 2017 (DOI: 10.1002/cncr.30783).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.30783

"Extreme Population-Level Events: Do They Have an Impact on Cancer?" Beti Thompson, Sarah Gehlert, and Electra D. Paskett. CANCER; Published Online: July 10, 2017 (DOI: 10.1002/cncr.30778).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.30778

Author Contact: Lee Gat, of the Sheba Medical Center, at [email protected] or 03- 530 3296.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.

Follow us on Twitter @JournalCancer and Facebook https://www.facebook.com/ACSJournals

About Wiley

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Media Contact

Dawn Peters
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1002/cncr.30783

Share12Tweet8Share2ShareShareShare2

Related Posts

Cellular Acyl-CoA Profiling Uncovers Mitochondrial CoA Transporters

September 9, 2025

Targeting NAD+ in Clinics: New Strategies and Challenges

September 9, 2025

Bee-Sting Inspired Microneedles from Chung-Ang University Poised to Transform Drug Delivery

September 9, 2025

Antibody–Bottlebrush Prodrugs Revolutionize Targeted Cancer Therapy

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Hsa_circ_0077007: New Hope for Colorectal Cancer

Extracting Easy-to-Digest Protein from Trout Residues

Fast Hyperspectral Imaging Quantifies Ship NO2, SO2 Emissions

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.